| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 3.3 | 2.3 |
| Gross profit | 1.6 | 1.0 |
| Profit before tax | 0.5 | -0.4 |
| Net income | 0.5 | -0.4 |
| EPS (diluted, $ a share) | $0.00 | $-0.00 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Revenue, year on year | +44.0% |
|---|---|
| Gross margin | 50.1% |
Source
Read the filing ↗
10-Q filed with the SEC. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Pharmaceutical Resource Technology, Inc.: key numbers
- Shares outstanding
- 2.85BLatest SEC cover page
- Sector
- Real Estate & Construction
- Industry
- General Bldg Contractors - Nonresidential BldgsSIC 1540
Today's reference numbers, updated daily. Not a valuation or a recommendation.